AIMP2 and colon carcinoma: Similar to AML, samples with an AIMP2-DX2/AIMP2 expression ratio ≥Q1 tended to exhibit an inferior OS in colon carcinoma (log-rank P = 0.28), and hepatocellular carcinoma (log-rank P = 0.24).